Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Medivir AB (publ) (ST: MVIR-B)

 
MVIR-B Technical Analysis
1
As on 17th Jul 2023 MVIR-B STOCK Price closed @ 7.00 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

MVIR-BSTOCK Price

Open 6.83 Change Price %
High 7.39 1 Day N/A N/A
Low 6.83 1 Week 0.00 0.00
Close 7.00 1 Month 0.00 0.00
Volume 6245 1 Year 0.00 0.00
52 Week High 0.00 | 52 Week Low 0.00
 
ST Sweden Most Active Stocks
TERRNT-B 0.38 %
TANGI 0.01 %
FING-B 0.07 %
SBB-B 6.21 %
OP 0.37 %
PROGEN 0.01 %
LUNE 21.97 6.65%
HDW-B 0.01 %
LIPI 0.08 %
XBRANE 0.17 %
 
ST Sweden Top Gainers Stocks
FEEL 0.09 12.50%
XPEC 2.52 7.69%
MAXF 50.20 6.81%
LUNE 21.97 6.65%
CARY 76.05 5.62%
LOYAL 7.36 5.44%
ZETA 8.15 4.76%
ZETA 8.15 4.76%
SECS 0.45 4.65%
ASPIRE 73.70 3.80%
 
ST Sweden Top Losers Stocks
ALLR 1.55 -26.54%
SARSYS 2.28 -8.06%
INVAJO 5.03 -7.20%
ECOWVE 4.30 -4.44%
CUR 2.17 -3.56%
CUR 2.17 -3.56%
PIEZO 31.90 -3.33%
GPXMED 2.49 -2.73%
ENDO 50.80 -2.68%
ENDO 50.80 -2.68%
 
 
MVIR-B
Daily Charts		 MVIR-B
Intraday Charts		 Whats New @
Bazaartrend		 MVIR-B
Free Analysis
 
MVIR-B Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
 
MVIR-B Forecast October 2024
Share
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
MVIR-B Weekly Forecast
4th UP Forecast0.00
3rd UP Forecast0.00
2nd UP Forecast0.00
1st UP Forecast0.00
1st DOWN Forecast0.00
2nd DOWN Forecast0.00
3rd DOWN Forecast0.00
4th DOWN Forecast0.00
 
MVIR-B Forecast2024
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
 
MVIR-B Other Details
Segment EQ
Market Capital 533393504.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
MVIR-B Address
MVIR-B
 
MVIR-B Latest News
 
Your Comments and Response on Medivir AB (publ)
 
MVIR-B Business Profile
Medivir AB (publ) researches, develops, and sells pharmaceuticals primarily for the treatment of oncology. The company markets Xerclear for use in the treatment of labial herpes under the Zoviduo name; and simeprevir. It develops Remetinostat, which has completed phase II clinical trial for treating cutaneous T-cell lymphoma, as well as in phase II clinical trial for treating basal cell carcinoma. The company also develops MIV-818, which is in phase Ia clinical trial for treating liver cancer; and MIV-711, which is in phase II clinical trial for treating osteoarthritis. It sells its products in Sweden, the Nordic region, Europe, the United States, and the rest of the world. The company has a research collaboration with the Drug Discovery and Development Platform at SciLifeLab for the discovery of antivirals for SARS CoV-2; and a licensing agreement with the Tango Therapeutics for a preclinical research program, as well as Ubiquigent Limited for the preclinical research program USP7. Medivir AB (publ) was founded in 1988 and is based in Huddinge, Sweden. Address: Lunastigen 7, Huddinge, Sweden, 141 22
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service